Drug intelligence / Profile preview

kaempferide

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral, Intravenous
01

Overview

**Kaempferide** is a naturally occurring O-methylated flavonol (a type of flavonoid) with the chemical formula C16H12O6. It is the 4′‑O‑methyl derivative of kaempferol and can be found in plants such as *Kaempferia galanga* (aromatic ginger), *Alpinia officinarum*, and others[1][2][9]. As a small molecule compound, kaempferide exhibits several biological activities including antioxidant, anti-inflammatory, anticancer (notably by inhibiting pancreatic cancer cell growth via blockade of an EGFR-related pathway), antihypertensive, antidiabetic effects and protection against myocardial ischemia/reperfusion injury through activation of the PI3K/Akt/GSK‑3β pathway[2][3][4][9]. It has also been reported to inhibit melanogenesis in vitro. Its mechanism involves modulation of multiple cellular signaling pathways relevant to oxidative stress and apoptosis. Currently it is considered an investigative or discovery agent rather than an approved pharmaceutical drug.

Other names
KaempferideKaempferid4'-Methylkaempferol4'-O-MethylkaempferolKaempferol 4'-methyl etherKaemperideCampherideKempferideUNII-508XL61MPDUNII508XL61MPDUNII 508XL61MPD4'-Methoxy-3,5,7-trihydroxyflavoneKAMPFERIDE3,5,7-Trihydroxy-(4-methoxyphenyl)-4H-chromen-oneEINECS 207–738–4
02

Targets

EGFR (Epidermal growth factor receptor)GSK3 (Glycogen synthase kinase 3 beta)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)AKT (RAC-alpha serine/threonine-protein kinase)

Beyond the preview

Go deeper on kaempferide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on kaempferide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call